EU member states out in the cold?
Discussions on how to tighten pharmacovigilance have opened up an old wound in EU affairs, revealing yet again how far this odd collection of countries still has to go before they will be able to act in anything approaching unison when it comes to medicines regulation. More...
FTC issues report on authorized generics
The Federal Trade Commission (FTC) last week issued an interim report that examined the effects of authorized generics on competition in the prescription drug market. An authorized generic exists when a pharmaceutical manufacturer sells a drug under both a brand-name and generic label. More...
UK strengthens medicines supply chain
The UK's Medicines and Healthcare Regulatory Agency (MHRA) has published the outcome of a consultation on measures to strengthen the country's medicines supply chain. More...
Join PTE on LinkedIn!
Join Pharmaceutical Technology Europe's group on LinkedIn. More...
Rheumatoid arthritis treatment gets EU thumbs up
The Committee for Medicinal Products for Human Use (CHMP) of the EMEA has recommended that the EC grants a marketing authorization for Belgium based-UCB's Cimzia, in combination with methotrexate, for the treatment of rheumatoid arthritis (RA). More...
European Knowledge Centre opened in the UK
Eisai (Japan) has opened its new European Knowledge Centre in Hertfordshire (UK) after investing approximately 117 million euro in the region to help develop new medicines for Alzheimer's Disease, Parkinson's Disease and epilepsy, as well as new treatments for cancer. More...
USP collaborates with Asian authorities
The US Pharmacopeial (USP) Convention and the Vietnamese Pharmacopoeia Commission (VPC) have signed a memorandum of understanding (MOU) that will help ensure the safety of Vietnamese medicines. More...
Artificial liver aids drug testing
Could artificial organs help replace animal experiments? Researchers at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB (Germany) believe so; they have developed an artificial liver that they believe will offer greater security for pharma companies and shorten the path to new drugs. More...
US Marshalls seize Caraco's drug products
On 25 June, US Marshalls seized all drug products and ingredients at three facilities of Caraco Pharmaceutical Laboratories: Detroit, Farmington Hills and Wixom (MI, USA) Michigan. More...
Tweet tweet!
Follow Pharmaceutical Technology Europe on Twitter. More...
|
